Preparation and evaluation of lyophilized liposome-encapsulated bufadienolides Liposome-encapsulated bufadienolides

Drug Development and Industrial Pharmacy

Volumn 35, Issue 9, 2009, Pages 1048-1058

  Li, Fang ^a   Yang, Rui ^a   Weng, Yan ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bufadienolides; Entrapment efficiency; Liposomes; Lyophilization; Microdialysis

Indexed keywords

BUFADIENOLIDE; BUFALIN; BUFOGENIN; CHOLESTEROL; CINOBUFAGIN; LIPID; LIPOSOME; OCTANOL; WATER;

ARTICLE; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; ENCAPSULATION; FILM; FREEZE DRYING; HYDRATION; LIPID COMPOSITION; MICRODIALYSIS; PARTICLE SIZE; PARTITION COEFFICIENT; PH; PHOTON CORRELATION SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAFILTRATION; ULTRASOUND;

ALGORITHMS; BUFANOLIDES; CALIBRATION; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; FREEZE DRYING; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MICRODIALYSIS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; PHARMACEUTICAL SOLUTIONS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; SUSPENSIONS; WATER;

EID: 70350688089     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040902762987     Document Type: Article

References (37)

1. Bangham AD, Standish MM, Watkins JC. (1965). Diffusion of univalent ions across the lamellae of swollen phosopholipids. JMol Biol, 13:238-252
2. Bekersky I, Fielding RM, Dressler DE, Kline S, Buell DN, Walsh TJ. (2001). Pharmacokinetics, excretion and mass balance of 14C-cholesterol-labeled AmBisome to healthy volunteers. J Clin Pharmacol, 41:963-971
3. Torchilin VP. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov, 4:145-160
4. Torrado JJ, Espada R, Ballesteros MP, Torrado-Santiago S. (2008). Amphotericin B Formulations and Drug Targeting. J Pharm Sci, 97:2405-2425
5. Antimisiaris SG, Ioannou PV, Loiseau PM. (2003). In-vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in-vivo distribution in BALB/c mice. J Pharm Pharmacol, 55:647-652
6. Han HD, Lee A, Song CK, Hwang T, Seong H, Lee CO, Shin BC. (2006). In vivo distribution and antitumor activity of heparinstabilized doxorubicin-loaded liposomes. Int J Pharm, 313:181-188
7. Zagana P, Haikou M, Klepetsanis P, Giannopoulou E, Ioannou PV, Antimisiaris SG. (2008). In vivo distribution of arsonoliposomes: Effect of vesicle lipid composition. Int J Pharm, 347:86-92.
8. Plock N, Kloft C. (2005). Microdialysis-theoretical background and recent implementation in applied life-sciences. Eur J Pharm Sci, 25:1-24.
9. Knaub SR, Chang MF, Lunte CE, Topp EM, Riley CM. (1995). Automated analytical systems for drug development studies part IV. A microdialysis system to study the partitioning of lomefloxacin across an erythrocyte membrane in vitro. J Pharm Biomed Anal, 14:121-129
10. Wang Z, Zhang Z, Fu Z, Chen D, Zhang X. (2003). Flow-injection chemiluminescence detection for studying protein binding of terbutaline sulfate with on-line microdialysis sampling. J Pharm Biomed Anal, 33:765-773
11. Yang X, Wang Y, Liu Y, Tang X. (2007). Effects of Panax quinquefolium protopanaxadiol saponins on the animal and human plasma protein binding of salvianolic acids in vitro. Asian J Pharm Sci, 2:170-179
12. Dash AK, Haney PW, Garavalia MJ. (1967). Development of an in vitro dissolution method using microdiaysis sampling technique for implantable drug delivery systems. J Pharm Sci, 88:1036-1040
13. Hitzman CJ, Wiedmann TS, Dai H, Elmquist WF. (2005). Measurement of drug release from microcarriers by microdialysis. J Pharm Sci, 94:1456-1466
14. Krenn L, Kopp B. (1998). Bufadienolides from animal and plant sources. Photochemistry, 48:1-29.
15. Steyn PS, Van Heerden FR. (1998). Bufadienolides of plant and animal origin. Nat Prod Rep, 15:397-413.
16. Hashimoto S, Jing Y, Kawazoe N, Masuda Y, Nakajo S, Yoshida T, et al. (1997). Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leukemia Res, 21:875-883
17. Kamano Y, Yamashita A, Nogawa T, Morita H, Takeya K, Itokawa H, et al. (2002). QSAR Evaluation of the Chan Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/51. J Med Chem, 45:5440-5447
18. Yeh JY, Huang WJ, Kan SF, Wang PS. (2003). Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate, 54:112-124
19. Chen KK, Kovarikove A. (1967). Pharmacology and toxicology of toad venom. J Pharm Sci, 56:1535-1541
20. Park JW. (2002). Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res, 4:95-99
21. Müller RH, Schmidt S, Buttle I, Akkar A, Schmitt J, Brömer S. (2004). Solemuls-novel technology for the formulation of i.v. emulsion with poorly soluble drugs. Int J Pharm, 269:293-302.
22. Li F, Wang T, He HB, Tang X. (2008). The properties of bufadienolides-loaded nano-emulsion and submicro-emulsion during lyophilization. Int J Pharm, 349:291-299
23. Kamano Y, Kamatsu M. (1969). Photochemistry of bufadienolides. I. Irradiation of bufalin, bufotalin and gamabufotalin. Chem Pharm Bull, 17:1698-1705
24. Linde H, Meyer K. (1958). Zur Konstitution des Resibufogenins und Artebufogenins. Experientia, 14:238-240
25. Ickenstein LM, Sandström MC, Mayer LD, Edwards K. (2006). Effects of phospholipid hydrolysis on the aggregate structure in DPPC/DSPE-PEG2000 liposome preparations after gel to liquid crystalline phase transition. Biochim Biophys Acta, 1758:171-180
26. Saetern AM, Skar M, Braaten A, Brandl M. (2005). Camptothecincatalyzed phospholipid hydrolysis in liposomes. Int J Pharm, 288:73-80.
27. Kepczynski M, Pandian RP, Smith KM, Ehrenberg B. (2002). Do liposome-binding constants of porphyrins correlate with their measured and predicted partitioning between octanol and water. Photochem Photobiol, 76:127-134
28. Mui B, Hope MJ. (2006). Formation of large unilamellar vesicles by extrusion. In: Gregoriadis G, ed. Liposome technology. New York: Informa Healthcare, 55-65.
29. Hao Y, Zhao F, Li N, Yang Y, Li K. (2002). Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm, 244:73-80.
30. Elhissi AM, O'Neill MA, Roberts SA, Taylor KM. (2006). A calorimetric study of dimyristoylphosphatidylcholine phase transitions and steroid-liposome interactions for liposomes prepared by thin film and proliposome methods. Int J Pharm, 320:124-130
31. Verly RM, Rodrigues MA, Daghastanli KR, Denadai AM, Cuccovia IM, Bloch Jr C, et al. (2008). Effect of cholesterol on the interaction of the amphibian antimicrobial peptide DD K with liposomes. Peptides, 29:15-24.
32. Miyajima K. (1997). Role of saccharides for the freeze-thawing and freeze drying of liposome. Adv Drug Deliv Rev, 24:151-159
33. Sasongko L, Williams KM, Ramzan I, McLachlan AJ. (2000). Assessment of in vitro and in vivo recovery of gallamine using microdialysis. J Pharmacol Toxicol Methods, 44:519-525
34. Martínez Martínez MS, Gutiérrez Hurtado B, Colino Gandarillas CI, Martínez Lanao J, Sánchez Navarro A. (2002). In vitro study of experimental factors affecting the microdialysis results. Anal Chim Acta, 459:143-150
35. Michalowski CB, Guterres SS, Dalla Costa T. (2004). Microdialysis for evaluating the entrapment and release of a lipophilic drug from nanoparticles. J Pharm Biomed Anal, 35:1093-1100
36. De Lange EC, De Boer AG, Breimer DD. (2000). Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv Drug Del Rev, 45:125-148
37. Lopes E, Pohlmann AR, Bassani V, Guterres SS. (2000). Polymeric colloidal systems containing ethionamide: Preparation and physico-chemical characterization. Pharmazie, 55:527-530